Use of stress testing prior to percutaneous coronary intervention in patients with stable coronary artery disease

References

• Rosamond W, Flegal K, Friday G et al. Heart disease and stroke statistics – 2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation115(5), E69–E171 (2007).
   PubMed Web of Science ®Google Scholar
• Boden WE, O’Rourke RA, Teo KK et al. Optimal medical therapy with or without PCI for stable coronary disease. N. Engl. J. Med.356(15), 1503–1516 (2007).
   PubMed Web of Science ®Google Scholar
• Weintraub WS, Spertus JA, Kolm P et al. Effect of PCI on quality of life in patients with stable coronary disease. N. Engl. J. Med.359(7), 677–687 (2008).
   PubMed Web of Science ®Google Scholar
• Bucher HC, Hengstler P, Schindler C, Guyatt GH. Percutaneous transluminal coronary angioplasty versus medical treatment for non-acute coronary heart disease: a meta-analysis of randomised controlled trials. BMJ321, 73–77 (2000).
   PubMedGoogle Scholar
• Katritsis DG, Ioannidis JP. Percutaneous coronary intervention versus medical therapy in nonacute coronary artery disease. Circulation111, 2906–2912 (2005).
   PubMed Web of Science ®Google Scholar
• Shomig A, Mehilli J, de Waha A et al. A meta-analysis of 17 randomized controlled trials of a percutaneous coronary intervention-based strategy in patients with stable coronary artery disease. J. Am. Coll. Cardiol.52, 894–904 (2008).
   PubMed Web of Science ®Google Scholar
• Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin. Ther.23(8), 1296–1310 (2001).
   PubMed Web of Science ®Google Scholar
• Newby LK, LaPointe NM, Chen AY et al. Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease. Circulation113(2), 203–212 (2006).
   PubMed Web of Science ®Google Scholar
• Mak KH, Belli G, Ellis SG, Moliterno DJ. Subacute stent thrombosis: evolving issues and current concepts. J. Am. Coll. Cardiol.27(2), 494–503 (1996).
   PubMed Web of Science ®Google Scholar
• Chen MS, John JM, Chew DP, Lee DS, Ellis SG, Bhatt DL. Bare metal stent restenosis is not a benign clinical entity. Am. Heart J.151(6), 1260–1264 (2006).
   PubMed Web of Science ®Google Scholar
• Morice MC, Serruys PW, Sousa JE et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N. Engl. J. Med.346(23), 1773–1780 (2002).
   PubMed Web of Science ®Google Scholar
• Stone GW, Ellis SG, O’Shaughnessy CD et al. Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial. JAMA295(11), 1253–1263 (2006).
   PubMed Web of Science ®Google Scholar
• Holmes DR Jr, Teirstein P, Satler L et al. Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trial. JAMA295(11), 1264–1273 (2006).
   PubMed Web of Science ®Google Scholar
• Colombo A, Drzewiecki J, Banning A et al. Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation108(7), 788–794 (2003).
   PubMed Web of Science ®Google Scholar
• Grube E, Silber S, Hauptmann KE et al. TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions. Circulation107(1), 38–42 (2003).
   PubMed Web of Science ®Google Scholar
• Stone GW, Moses JW, Ellis SG et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N. Engl. J. Med.256, 998–1008 (2007).
   Google Scholar
• Lagerqvist B, James SK, Stenestrand U, Lindback J, Nilsson T, Wallntin L. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N. Engl. J. Med.356, 1009–1019 (2007).
   PubMed Web of Science ®Google Scholar
• Pfisterer ME, Brunner-LaRocca HP, Buser PT et al. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents. J. Am. Coll. Cardiol.48, 2584–2591 (2006).
   PubMed Web of Science ®Google Scholar
• Iakovou I, Schmidt T, Bonizzoni E et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA293(17), 2126–2130 (2005).
   PubMed Web of Science ®Google Scholar
• Mehta SR, Yusuf S, Peters RJ et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet358(9281), 527–533 (2001).
   PubMed Web of Science ®Google Scholar
• Steinhubl SR, Berger PB, Mann JT 3rd et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA288(19), 2411–2420 (2002).
   PubMed Web of Science ®Google Scholar
• Bhatt DL, Fox KA, Hacke W et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N. Engl. J. Med.354(16), 1706–1717 (2006).
   PubMed Web of Science ®Google Scholar
• Arnett EN, Isner JM, Redwood DR et al. Coronary artery narrowing in coronary heart disease: comparison of cineangiographic and necropsy findings. Ann. Intern. Med.91(3), 350–356 (1979).
   PubMed Web of Science ®Google Scholar
• Isner JM, Kishel J, Kent KM, Ronan JA Jr, Ross AM, Roberts WC. Accuracy of angiographic determination of left main coronary arterial narrowing. Angiographic–histologic correlative analysis in 28 patients. Circulation63(5), 1056–1064 (1981).
   PubMed Web of Science ®Google Scholar
• Blankenhorn DH, Curry PJ. The accuracy of arteriography and ultrasound imaging for atherosclerosis measurement. A review. Arch. Pathol. Lab. Med.106(10), 483–489 (1982).
   PubMed Web of Science ®Google Scholar
• White CW, Wright CB, Doty DB et al. Does visual interpretation of the coronary arteriogram predict the physiologic importance of a coronary stenosis? N. Engl. J. Med.310(13), 819–824 (1984).
   PubMed Web of Science ®Google Scholar
• Lindstaedt M, Spiecker M, Perings C et al. How good are experienced interventional cardiologists at predicting the functional significance of intermediate or equivocal left main coronary artery stenoses? Int. J. Cardiol.120(2), 254–261 (2007).
   PubMed Web of Science ®Google Scholar
• Brueren BR, ten Berg JM, Suttorp MJ et al. How good are experienced cardiologists at predicting the hemodynamic severity of coronary stenoses when taking fractional flow reserve as the gold standard. Int. J. Cardiovasc. Imaging18(2), 73–76 (2002).
   PubMed Web of Science ®Google Scholar
• Topol EJ, Nissen SE. Our occupation with coronary luminology: the dissociation between clinical and angiographic findings in ischemic heart disease. Circulation92, 2333–2342 (1995).
   PubMed Web of Science ®Google Scholar
• Lin GA, Dudley RA, Redberg RF. Cardiologists’ use of percutaneous coronary interventions for stable coronary artery disease. Arch Intern. Med.167(15), 1604–1609 (2007).
   PubMed Web of Science ®Google Scholar
• Ambrose JA, Tannenbaum MA, Alexopoulos D et al. Angiographic progression of coronary artery disease and the development of myocardial infarction. J. Am. Coll. Cardiol.12(1), 56–62 (1988).
   PubMed Web of Science ®Google Scholar
• Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation107(23), 2900–2907 (2003).
   PubMed Web of Science ®Google Scholar
• Shaw LJ, Berman DS, Maron DJ et al. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation117(10), 1283–1291 (2008).
   PubMed Web of Science ®Google Scholar
• Hochman JS, Lamas GA, Buller CE et al. Coronary intervention for persistent occlusion after myocardial infarction. N. Engl. J. Med.355 (2006).
   PubMedGoogle Scholar
• Cantor WJ, Baptista SB, Srinivas VS et al. Impact of stress testing before percutaneous coronary intervention or medical management on outcomes of patients with persistent total occlusion after myocardial infarction: analysis from the occluded artery trial. Am. Heart J.157(4), 666–672 (2009).
   PubMed Web of Science ®Google Scholar
• Tonino PA, De Bruyne B, Pijls NH et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N. Engl. J. Med.360(3), 213–224 (2009).
   PubMed Web of Science ®Google Scholar
• Sant’Anna FM, Silva EE, Batista LA, Ventura FM, Barrozo CA, Pijls NH. Influence of routine assessment of fractional flow reserve on decision making during coronary interventions. Am. J. Cardiol.99(4), 504–508 (2007).
   PubMed Web of Science ®Google Scholar
• Takagi A, Tsurumi Y, Ishii Y, Suzuki K, Kawana M, Kasanuki H. Clinical potential of intravascular ultrasound for physiological assessment of coronary stenosis: relationship between quantitative ultrasound tomography and pressure-derived fractional flow reserve. Circulation100(3), 250–255 (1999).
   PubMed Web of Science ®Google Scholar
• Nishioka T, Amanullah AM, Luo H et al. Clinical validation of intravascular ultrasound imaging for assessment of coronary stenosis severity: comparison with stress myocardial perfusion imaging. J. Am. Coll. Cardiol.33(7), 1870–1878 (1999).
   PubMed Web of Science ®Google Scholar
• Briguori C, Anzuini A, Airoldi F et al. Intravascular ultrasound criteria for the assessment of the functional significance of intermediate coronary artery stenoses and comparison with fractional flow reserve. Am. J. Cardiol.87(2), 136–141 (2001).
   PubMed Web of Science ®Google Scholar
• Jasti V, Ivan E, Yalamanchili V, Wongpraparut N, Leesar MA. Correlations between fractional flow reserve and intravascular ultrasound in patients with an ambiguous left main coronary artery stenosis. Circulation110(18), 2831–2836 (2004).
   PubMed Web of Science ®Google Scholar
• Sano K, Mintz GS, Carlier SG et al. Assessing intermediate left main coronary lesions using intravascular ultrasound. Am. Heart J.154(5), 983–988 (2007).
   PubMed Web of Science ®Google Scholar
• Kern MJ, Dupouy P, Drury JH et al. Role of coronary artery lumen enlargement in improving coronary blood flow after balloon angioplasty and stenting: a combined intravascular ultrasound Doppler flow and imaging study. J. Am. Coll. Cardiol.29(7), 1520–1527 (1997).
   PubMed Web of Science ®Google Scholar
• Fassa AA, Wagatsuma K, Higano ST et al. Intravascular ultrasound-guided treatment for angiographically indeterminate left main coronary artery disease: a long-term follow-up study. J. Am. Coll. Cardiol.45(2), 204–211 (2005).
   PubMed Web of Science ®Google Scholar
• Okabe T, Mintz GS, Lee SY et al. Five-year outcomes of moderate or ambiguous left main coronary artery disease and the intravascular ultrasound predictors of events. J. Invasive Cardiol.20(12), 635–639 (2008).
   PubMed Web of Science ®Google Scholar
• Abizaid AS, Mintz GS, Mehran R et al. Long-term follow-up after percutaneous transluminal coronary angioplasty was not performed based on intravascular ultrasound findings: importance of lumen dimensions. Circulation100(3), 256–261 (1999).
   PubMed Web of Science ®Google Scholar
• Bech GJ, Droste H, Pijls NH et al. Value of fractional flow reserve in making decisions about bypass surgery for equivocal left main coronary artery disease. Heart86(5), 547–552 (2001).
   PubMed Web of Science ®Google Scholar
• Smith SC Jr, Feldman TE, Hirshfeld JW Jr et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention). Circulation113(7), E166–E286 (2006).
   PubMedGoogle Scholar
• Lucas FL, DeLorenzo MA, Siewers AE, Wennberg DE. Temporal trends in the utilization of diagnostic testing and treatments for cardiovascular disease in the United States, 1993–2001. Circulation113, 374–379 (2006).
   PubMed Web of Science ®Google Scholar
• Lin GA, Dudley RA, Lucas FL, Malenka DJ, Vittinghoff E, Redberg RF. Frequency of stress testing to document ischemia prior to elective percutaneous coronary intervention. JAMA300(15), 1765–1773 (2008).
   PubMed Web of Science ®Google Scholar
• Epstein AM, Weissman JS, Schneider EC, Gatsonis C, Leape LL, Piana RN. Race and gender disparities in rates of cardiac revascularization. Med. Care41(11), 1240–1255 (2003).
   PubMed Web of Science ®Google Scholar
• Kressin NR, Petersen LA. Racial differences in the use of invasive cardiovascular procedures: review of the literature and prescription for future research. Ann. Intern. Med.135, 352–366 (2001).
   PubMed Web of Science ®Google Scholar
• Lucas FL, Siewers AE, DeLorenzo MA, Wennberg DE. Differences in cardiac stress testing by sex and race among Medicare beneficiaries. Am. Heart J.154(3), 502–509 (2007).
   PubMed Web of Science ®Google Scholar
• Wennberg DE, Kellett MA, Dickens JD, Malenka DJ, Keilson LM, Keller RB. The association between local diagnostic testing intensity and invasive cardiac procedures. JAMA275, 1161–1164 (1996).
   PubMed Web of Science ®Google Scholar
• Nallamothu BK, Rogers MAM, Chernew ME, Krumholz HM, Eagle KA, Birkmeyer JD. Opening of specialty cardiac hospitals and use of coronary revascularization in Medicare beneficiaries. JAMA297, 962–968 (2007).
   PubMed Web of Science ®Google Scholar
• Wennberg D, Dickens J Jr, Soule D et al. The relationship between the supply of cardiac catheterization laboratories, cardiologists and the use of invasive cardiac procedures in northern New England. J. Health Serv. Res. Policy2(2), 75–80 (1997).
   PubMedGoogle Scholar
• Ko DT, Wang Y, Alter DA et al. Regional variation in cardiac catheterization appropriateness and baseline risk after acute myocardial infarction. J. Am. Coll. Cardiol.51(7), 716–723 (2008).
   PubMed Web of Science ®Google Scholar
• Stukel TA, Lucas FL, Wennberg DE. Long-term outcomes of regional variations in intensity of invasive vs medical management of Medicare patients with acute myocardial infarction. JAMA293(11), 1329–1337 (2005).
   PubMed Web of Science ®Google Scholar
• Shaw LJ, Hachamovitich R, Berman DS et al. The economic consequences of available diagnostic and prognostic strategies for the evaluation of stable angina patients: an observational assessment of the value of precatheterization ischemia. J. Am. Coll. Cardiol.33, 661–669 (1999).
   PubMed Web of Science ®Google Scholar
• Kim C, Kwok YS, Saha S, Redberg RF. Diagnosis of suspected coronary artery disease in women: a cost–effectiveness analysis. Am. Heart J.137(6), 1019–1027 (1999).
   PubMed Web of Science ®Google Scholar
• Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. Stress myocardial perfusion single-photon emission computed tomography is clinically effective and cost effective in risk stratification of patients with a high likelihood of coronary artery disease (CAD) but no known CAD. J. Am. Coll. Cardiol.43(2), 200–208 (2004).
   PubMed Web of Science ®Google Scholar
• Sharples L, Hughes V, Crean A et al. Cost–effectiveness of functional cardiac testing in the diagnosis and management of coronary artery disease: a randomised controlled trial. The CECaT trial. Health Technol. Assess.11(49), iii–iv, ix–115 (2007).
   PubMedGoogle Scholar
• Gibbons RJ, Balady GJ, Bricker JT et al. ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). Circulation106(14), 1883–1892 (2002).
   PubMed Web of Science ®Google Scholar
• Fleischmann KE, Hunink MG, Kuntz KM, Douglas PS. Exercise echocardiography or exercise SPECT imaging? A meta-analysis of diagnostic test performance. JAMA280(10), 913–920 (1998).
   PubMed Web of Science ®Google Scholar
• Morgan MW, Deber RB, Llewellyn-Thomas HA et al. Randomized, controlled trial of an interactive videodisc decision aid for patients with ischemic heart disease. J. Gen. Intern. Med.15(10), 685–693 (2000).
   PubMed Web of Science ®Google Scholar
• Duffy SJ, Gelman JS, Peverill RE, Greentree MA, Harper RW, Meredith IT. Agreement between coronary flow velocity reserve and stress echocardiography in intermediate-severity coronary stenoses. Catheter Cardiovasc. Interv.53(1), 29–38 (2001).
   PubMed Web of Science ®Google Scholar
• Lachance P, Dery JP, Rodes-Cabau J et al. Impact of fractional flow reserve measurement on the clinical management of patients with coronary artery disease evaluated with noninvasive stress tests prior to cardiac catheterization. Cardiovasc. Revasc. Med.9(4), 229–234 (2008).
   PubMedGoogle Scholar
• Courtis J, Rodes-Cabau J, Larose E et al. Usefulness of coronary fractional flow reserve measurements in guiding clinical decisions in intermediate or equivocal left main coronary stenoses. Am. J. Cardiol.103(7), 943–949 (2009).
   PubMed Web of Science ®Google Scholar
• Meijboom WB, Mollet NR, Van Mieghem CA et al. 64-slice CT coronary angiography in patients with non-ST elevation acute coronary syndrome. Heart93(11), 1386–1392 (2007).
   PubMed Web of Science ®Google Scholar